A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture

Archives of Virology

Volumn 142, Issue 7, 1997, Pages 1365-1380

  Barrere B ^a   Driguez, P A ^b   Maudrin, J ^b   Doutheau, A ^b   Aymard, M ^c   Quash, G ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Laboratoire d'Immunologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIFLUOROMETHYLPHENYL KETOSIDE N ACETYLNEURAMINIC ACID; 2-DIFLUOROMETHYLPHENYL-KETOSIDE-N-ACETYLNEURAMINIC ACID; 4 DIFLUOROMETHYL 2 METHOXYPHENYL KETOSIDE N ACETYLNEURAMINIC ACID; 4-DIFLUOROMETHYL-2-METHOXYPHENYL-KETOSIDE-N-ACETYLNEURAMINIC ACID; ANTIVIRUS AGENT; ENZYME INHIBITOR; SIALIC ACID DERIVATIVE; SIALIDASE; VIRUS PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CLOSTRIDIUM PERFRINGENS; DOG; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEMAGGLUTINATION; INFLUENZA VIRUS A; PHYSIOLOGY; VIRION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; CLOSTRIDIUM PERFRINGENS; DOGS; ENZYME INHIBITORS; HEMAGGLUTINATION, VIRAL; INFLUENZA A VIRUS; NEURAMINIDASE; SIALIC ACIDS; VIRAL PROTEINS; VIRION; VIRUS REPLICATION;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; CLOSTRIDIUM PERFRINGENS; INFLUENZA VIRUS; INFLUENZAVIRUS A;

EID: 0030802973     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050166     Document Type: Article

References (21)

1. Burnet FM (1948) Mucins and mucoids in relation to influenza virus action. IV. Inhibition by purified mucoid of infection and haemagglutinin with the virus strain WSE. Aust J Exp Biol Med Sci 26: 381-387
2. Burnet FM, Mc Crea JF, Anderson SG (1947) Mucin as substrate of enzyme action by viruses of the mumps influenza group. Nature 160: 404-405
3. Colman PM (1989) Neuraminidase. Enzyme and antigen. In: Krug RM (ed) The influenza viruses. Plenum Press, New York, pp 175-218
4. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, WebberJones J (1982) A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 307: 580-584
5. Driguez PA, Barrere B, Chantegrel B, Deshayes C, Doutheau A, Quash G (1992) Synthesis of sodium salt of ortho-(difluoromethyl)phenyl-α-ketoside of W-acetylneuraminic acid: a mechanism-based inhibitor of Clostridium perfringens neuraminidase. BioMed Chem Lett 2: 1361-1366
6. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH (1985) The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4: 3021-3024
7. Kitz R, Wilson IB (1962) Esters of methanedsulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem 237: 3245-3249
8. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
9. Lambre RC, Terzidis H, Greffard A, Webster RG (1991) An enzyme-linked lectin assay for sialidase. Clin Chim Acta 198: 183-194
10. Meindl P, Bodo G, Linder J, Palese P (1971) Influence of 2-deoxy 2,3-dehydro-N-acetylneuraminic acid on myxovirus sialidases and the replication of influenza and Newcastle disease virus. Z Naturforsch 263: 792-797
11. Meindl P, Bodo G, Palese P, Schulman J, Tuppy H (1974) Inhibition of sialidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 58: 457-463
12. Nagai T, Miyaichi Y, Tomimori T, Suzuki Y, Yamada H (1992) In vivo anti-influenza virus activity of plant flavonoids possessing inhibitory activity for influenza virus sialidase. Antiviral Res 19: 207-217
13. Nagy JO, Wang P, Gilbert JH, Schaefer ME, Hill TG, Callstrom MRB, Bednarski MD (1992) Carbohydrate materials bearing neuraminidase-resistant C-glycosides of sialic 1380 B. Barrère et al.: Novel sialidase inhibitors and influenza virus infectivity acid strongly inhibit the in vitro infectivity of influenza virus. J Med Chem 35: 4501-4502
14. Palese P, Compans RW (1976) Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol 33: 159-163
15. Palese P, Tobita K, Ueda M, Compans RW (1974) Characterisation of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61: 397-410
16. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, DeClercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20: 309-321
17. Quash GA, Thomas V, Ogier G, El Alaoui S, Delcros JG, Ripoll H, Roch AM, Legastelois S, Gibert R, Ripoll JP (1989) Diagnostic and therapeuthic procedures with haptens and glycoproteins (antigens and antibodies) coupled covalently by specific sites to insoluble supports. In: Quash GA, Rodwell JD (eds) Covalently modified antigens and antibodies in diagnosis and therapy. Marcel Dekker, New York, pp 155-185
18. Rando RR (1984) Mechanism-based enzyme inactivators. Pharm Rev 36: 111-138
19. Schauer R (1982) Sialic acids. Adv Carbohydr Chem Biochem 40: 131-234
20. Von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van PT, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418-423
21. Walsh C (1982) Suicide substrates: mechanism-based enzyme inactivators. Tetrahedron 38: 871-909